An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma

Genentech

Status: Completed

Conditions: Lymphoma, Non Hodgkin

Study type: Observational

Funder types: Industry

Identifiers

NCT00097565

U2963n

Details and patient eligibility

About

This is a prospective, observational, longitudinal, multicenter study of patients with newly diagnosed follicular Non Hodgkin's Lymphoma (NHL) designed to delineate differences in clinical outcome by comparing the effectiveness and safety of common treatment regimens.

Enrollment: 2,740 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed Informed Consent Form (unless the Institutional Review Board [IRB] has granted a waiver of consent)
• Signed Authorization for the Use and Disclosure of Health Information document
• Age ≥18 years
• Histologic documentation of follicular NHL, according to Revised European-American Lymphoma (REAL) classification system, as assessed by the local pathologist and treating physician
• Initial diagnosis of follicular B-cell NHL within 6 months prior to enrollment
• Availability of cancer-specific historical data points in the patient's medical records

Exclusion criteria

• Other indolent or histologic NHL subtypes
• Diagnosis of lymphoma > 6 months prior to enrollment